GILEAD SCIENCES, INC.·4

Jun 2, 6:04 PM ET

O'Day Daniel Patrick 4

4 · GILEAD SCIENCES, INC. · Filed Jun 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Gilead CEO Daniel O'Day Sells 15,000 Shares

What Happened Daniel Patrick O'Day, Chairman & CEO of Gilead Sciences (GILD), sold a total of 15,000 shares in open-market transactions on June 1, 2026. The sales break down as: 10,900 shares @ $131.10 for $1,428,983; 3,062 shares @ $132.22 for $404,843; and 1,038 shares @ $132.97 for $138,021 — total proceeds ~$1,971,847. These were dispositions (sales), not purchases.

Key Details

  • Date of transactions: June 1, 2026 (Form 4 filed June 2, 2026).
  • Individual trades: 10,900 @ $131.10; 3,062 @ $132.22; 1,038 @ $132.97.
  • Total shares sold / proceeds: 15,000 shares / ~$1.97M.
  • Shares owned after transaction: not specified in the supplied filing data.
  • Notable footnotes: F1 — transactions were made pursuant to a Rule 10b5-1 trading plan adopted Feb 25, 2026. F2–F4 — sale-price ranges are reported; a full breakdown by specific prices is available to the SEC, issuer, or shareholders on request.
  • Timeliness: Filing was made the next day (June 2) for June 1 trades — appears timely.

Context Sales executed under a Rule 10b5-1 plan are prearranged trades and are commonly used by insiders to sell shares on a schedule. Such sales are routine disclosures of insider activity and do not, by themselves, indicate management’s view of the company’s prospects.

Insider Transaction Report

Form 4
Period: 2026-06-01
O'Day Daniel Patrick
DirectorChairman & CEO
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-06-01$131.10/sh10,900$1,428,983621,667 total
  • Sale

    Common Stock

    [F1][F3]
    2026-06-01$132.22/sh3,062$404,843618,605 total
  • Sale

    Common Stock

    [F1][F4]
    2026-06-01$132.97/sh1,038$138,021617,567 total
Footnotes (4)
  • [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • [F2]Sale prices for the transactions reported range from $130.66 to $131.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
  • [F3]Sale prices for the transactions reported range from $131.71 to $132.70. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
  • [F4]Sale prices for the transactions reported range from $132.71 to $133.295. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day|2026-06-02

Documents

1 file
  • 4
    wk-form4_1780437841.xmlPrimary

    FORM 4